Belzutifan is active in VHL-related cancers
- PMID: 34893759
- DOI: 10.1038/s41571-021-00587-w
Belzutifan is active in VHL-related cancers
Comment on
-
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.N Engl J Med. 2021 Nov 25;385(22):2036-2046. doi: 10.1056/NEJMoa2103425. N Engl J Med. 2021. PMID: 34818478 Free PMC article. Clinical Trial.
References
Original article
-
- Jonasch, E. et al. Belzutifan for renal cell carcinoma in von Hippel–Lindau disease. N. Engl. J. Med. 385, 2036–2046 (2021) - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
